Merck & Co ties up with Welcome Trust for vaccines

Drug firm Merck & Co today said it has formed a joint venture with

RELATED ARTICLES Bharat Biotech to invest Rs 325cr for clinical research Global CEOs want faster clearances, uniform tax Globalisation rules must take India, others on board Investment to drive growth; India needs $250b: ICICI Bank Worst is over; bumps and opportunity go together: Premji

UK-based charitable organistation Welcome Trust to develop vaccines for the developing countries.

"We along with charitable organisation Welcome Trust have formed a 50:50 joint venture, which would be based in India and would conduct research and development activities in the field of vaccines," MSD Technology Singapore Pte Ltd President (Asia Pacific Human Health) Ramesh Subrahmanian told reporters on the sidelines of India Economic Summit organised by WEF and CII here.

MSD is a subsidiary of US-based drug firm Merck & Co Inc. Welcome Trust is the largest charitable organisation in the UK. It funds innovative biomedical research in the UK and globally and has spent around 600 million pounds in such activities last year.